Overexpression of EP4 with cAMP-PKA signal activation promoted the castration-resistant progression of LNCaP cells through AR activation. Overexpression.

Slides:



Advertisements
Similar presentations
Supplemental Figure 1 a % pulldown from input LNCaP/scrambled-siRNA Figure 1 A, ChIP analysis of AR and PHB binding to the PSA promoter in the LNCaP/scrambled-siRNA.
Advertisements

The Calcium Paradoxon of Renin Release
Volume 19, Issue 5, Pages (May 2011)
Pirh2 promotes p73 ubiquitination in vivo.
NRP2 represses IGF-IR expression and signaling.
CHK1 downregulation upon ERG overexpression.
Volume 10, Issue 8, Pages (March 2015)
A, left: indicated MEFs were transfected as described in the Methods section. A, left: indicated MEFs were transfected as described in the Methods section.
Spatial and Temporal Recruitment of Androgen Receptor and Its Coactivators Involves Chromosomal Looping and Polymerase Tracking  Qianben Wang, Jason S.
Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.
Overexpression of HGF decreases MET protein levels.
William G. Nelson, Michael C. Haffner, Srinivasan Yegnasubramanian 
USP2a-dependent miRs deregulation modulates MYC expression.
USP2a overexpression modifies the microRNA expression profile of prostate cells. USP2a overexpression modifies the microRNA expression profile of prostate.
eIF5A-PEAK1 signaling regulates KRAS protein expression.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
Allopurinol up-regulates DR5 expression in PC-3 and DU145 cells.
JAK3A572V mutation causes constitutive JAK3 activity and IL-2–independent proliferation of NKTCL cells. JAK3A572V mutation causes constitutive JAK3 activity.
PKIs block DHT + bombesin-induced transactivation of probasin ARR3 tk-luc and PSA pPUE-E1b-Luc report constructs. PKIs block DHT + bombesin-induced transactivation.
MiR-431-5p directly targets RAF1 and is negatively correlated to RAF1 expression (A) The predicted binding sites of miR-431-5p and RAF1 3′-UTR, and mutant.
Expression of PKCδ in islets and other tissues of control and PKCδKN-overexpressing mice. Expression of PKCδ in islets and other tissues of control and.
The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI  Feng Xing, Shuo Wang, Jianhong Zhou  Molecular.
FOXO3a phosphorylation and expression.
SiRNA screening identifies genes required for the viability of Pim1-ovexpressing prostate cells. siRNA screening identifies genes required for the viability.
The SFKs confer BRAF inhibitor resistance in BRAF-mutant melanoma cells. The SFKs confer BRAF inhibitor resistance in BRAF-mutant melanoma cells. A, phospho-protein.
The selective depletion of DTR-expressing FAP+/CD45+ and FAP+/CD45− tumoral cells from bone marrow chimeric mice by the administration of DTX. A, sketch.
Quercetin induces arrest in G1 phase of cell cycle in P39 xenografts.
Quercetin induces apoptosis in P39 xenografts.
Depletion of HDAC2 sensitizes cells to epirubicin-induced apoptosis.
The effect of IAA on tumor growth in an SK-MEL-28 xenograft model.
VEGF expression in neoplastic and normal prostate tissue.
A, one-step viral growth curves: RT treatment increased the virus yield in MV-CEA–treated U87 cells by up to 2 log as compared with MV-CEA infection only.
Expression of CRC stem cell markers and L1 in CRC cells.
Active AR signaling in enzalutamide-resistant xenograft tumors.
Bcl-xL expression in tumors antagonizes the therapeutic efficiency of ERBB2 downregulation. Bcl-xL expression in tumors antagonizes the therapeutic efficiency.
Endothelial cells/microvasucles are increased in prostate cancer versus normal tissues. Endothelial cells/microvasucles are increased in prostate cancer.
Effect of SFN on the protein expression of Nrf2, HO-1, and NQO1 in JB6-shMock and JB6-shNrf2 cells. Effect of SFN on the protein expression of Nrf2, HO-1,
TFAP2A knockdown inhibits cell growth by targeting HIF-1α signaling.
In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. In vivo tumorigenicity of MKN-1 cells with sustained suppression of HDAC2. A,
IGF-IR in human head and neck cancer.
Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma cells. Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma.
FOXO-responsive 3X-IRS promoter activity is reduced in LNAI cells versus LNCaP cells. FOXO-responsive 3X-IRS promoter activity is reduced in LNAI cells.
Pharmacodynamic evaluation of VT-464 and ABI in MR49F xenograft model.
DNA demethylation reactivates GSN expression in gastric cancer cells.
Pirh2 represses p73-dependent transactivation.
Effect of the crystal form and solid dispersion preparations of KRN633 on the growth of human tumor xenografts in mice. Effect of the crystal form and.
miR-100 suppresses bladder cancer cell growth in vitro and in vivo.
Isolation of stable XPAKD and XPCKD HeLa clones.
NT157 treatment inhibits LNCaP xenograft growth and delays castration-resistant progression. NT157 treatment inhibits LNCaP xenograft growth and delays.
Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.
Effect of NO and eNOS on prostate cancer cell growth.
Effect of SPINDLIN1 protein on cancer cell proliferation and invasion.
PVT1 facilitated gastric cancer progression in a FOXM1-mediated manner
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and HAL-treated xenografts. Expression of HIF-1α and β-catenin in hypoxic HCC cell lines and.
Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter. Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter.
RhuαVEGF and rhuαVEGF/paclitaxel mediated growth inhibition in an androgen-independent prostate cancer xenograft model. rhuαVEGF and rhuαVEGF/paclitaxel.
Fig. 2 Increasing KLF17, CDH1, and LASS2 expression reduced malignant progression and promoted apoptosis of tumor cells. Increasing KLF17, CDH1, and LASS2.
Targeting GAPLINC decreased CD44 expression and tumor growth in vivo.
Proliferation of TA3-Ha and TA3-St cells in vitro and in vivo.
HOXA11-AS acts as a ceRNA for miR-1297.
MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.
Effects of W. chinensis extract on androgen activity and growth of prostate cancer cells. Effects of W. chinensis extract on androgen activity and growth.
Validation of KMT2D function in MM23, MM2, and MM25 PDXs
Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.
Effect of SFN on the total activity and protein expression of HDACs in JB6 P+ cells. Effect of SFN on the total activity and protein expression of HDACs.
TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.
miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.
Expression of PKM2 Y105F mutant in H1299 cells leads to decreased proliferation under hypoxic conditions, increased oxidative phosphorylation and reduced.
AXL knockout does not prevent dormancy.
Presentation transcript:

Overexpression of EP4 with cAMP-PKA signal activation promoted the castration-resistant progression of LNCaP cells through AR activation. Overexpression of EP4 with cAMP-PKA signal activation promoted the castration-resistant progression of LNCaP cells through AR activation. A, EP4 protein expression detected with Western blotting in LNCaP-EP4(A) and LNCaP-EP4(B) compared with LNCaP-mock (top), intracellular cAMP concentrations, PSA expression, and cell proliferation ratio versus day 0 in androgen-depleted conditions (CSFBS) for 6 d (bottom). *, P < 0.05; **, P < 0.005 versus LNCaP-mock. B, AR expression attenuated using a stealth RNAi system detected with Western blotting (top), PSA expression levels on day 4 (middle), and cell proliferation ratio on days 2 and 4 versus day 0 (bottom) in CSFBS. *, P < 0.05; **, P < 0.005 versus LNCaP-mock. C, relative luciferase activities of PSAp-Luc in LNCaP cells with transfection of pcDNA3.1-mock and pcDNA3.1-EP4 in CSFBS and 5α-dihydrotestosterone (DHT) stimulation, respectively. *, P < 0.05; **, P < 0.005 versus control (left). PSA expression of LNCaP cells in CSFBS for 6 d under the administration of forskolin, dbcAMP, and H-89. *, P < 0.05; **, P < 0.005 versus preadministration (right). D, the sequential changes in xenograft tumor volume after the castration of mice (1 × 107 cells, n = 5 each). *, P < 0.05. Naoki Terada et al. Cancer Res 2010;70:1606-1615 ©2010 by American Association for Cancer Research